Big pharma pushes back against WHO patent pool

The leaders of some of the world’s largest pharma companies appear to be resistant to a World Health Organization (WHO) voluntary pool aimed at making vaccines, tests, treatments and other health technologies to fight COVID-19 accessible to all.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

EC backs voluntary COVID-19 vaccine licensing

18 June 2020 The European Commission has backed voluntary IP licensing as part of its new vaccines strategy.

Americas

BIO 2020: IP’s vital role in COVID-19 fight, potential ‘chaos’ of pooling

9 June 2020 Concerns that IP is hindering the development of tools to fight the COVID-19 are unfounded, and now is the time that we need IP the most, according to big pharma representatives.

Big Pharma

Has the public got the taste for free medicine?

5 June 2020 The COVID-19 pandemic has seen the fundamental principles of the IP system called into question. How can we go on as before?